Champlain Investment Partners LLC Buys 5,740 Shares of Transcat, Inc. (NASDAQ:TRNS)

Champlain Investment Partners LLC lifted its holdings in shares of Transcat, Inc. (NASDAQ:TRNSGet Rating) by 1.8% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 328,135 shares of the scientific and technical instruments company’s stock after buying an additional 5,740 shares during the period. Champlain Investment Partners LLC’s holdings in Transcat were worth $30,330,000 as of its most recent filing with the SEC.

Several other institutional investors have also bought and sold shares of the company. Dorsey Wright & Associates raised its holdings in shares of Transcat by 15.4% during the 4th quarter. Dorsey Wright & Associates now owns 1,079 shares of the scientific and technical instruments company’s stock worth $100,000 after buying an additional 144 shares in the last quarter. Royal Bank of Canada raised its holdings in shares of Transcat by 30.4% during the 3rd quarter. Royal Bank of Canada now owns 631 shares of the scientific and technical instruments company’s stock worth $40,000 after buying an additional 147 shares in the last quarter. Citigroup Inc. raised its holdings in shares of Transcat by 140.1% during the 3rd quarter. Citigroup Inc. now owns 809 shares of the scientific and technical instruments company’s stock worth $52,000 after buying an additional 472 shares in the last quarter. Denali Advisors LLC acquired a new position in shares of Transcat during the 4th quarter worth $46,000. Finally, Victory Capital Management Inc. raised its holdings in shares of Transcat by 0.4% during the 4th quarter. Victory Capital Management Inc. now owns 156,647 shares of the scientific and technical instruments company’s stock worth $14,479,000 after buying an additional 560 shares in the last quarter. 75.11% of the stock is owned by institutional investors.

In other Transcat news, Director Gary J. Haseley bought 1,305 shares of the business’s stock in a transaction that occurred on Tuesday, February 15th. The shares were bought at an average price of $76.62 per share, for a total transaction of $99,989.10. The purchase was disclosed in a filing with the SEC, which is available through this link. Also, CEO Lee D. Rudow sold 5,210 shares of the stock in a transaction that occurred on Saturday, March 26th. The stock was sold at an average price of $74.21, for a total value of $386,634.10. The disclosure for this sale can be found here. Corporate insiders own 6.60% of the company’s stock.

Shares of TRNS stock traded down $1.10 on Thursday, hitting $70.36. The company had a trading volume of 77,995 shares, compared to its average volume of 44,039. The firm has a market cap of $529.04 million, a P/E ratio of 46.02 and a beta of 0.82. The stock’s 50-day moving average is $76.48 and its two-hundred day moving average is $83.15. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.77 and a current ratio of 2.34. Transcat, Inc. has a twelve month low of $46.17 and a twelve month high of $101.05.

A number of equities analysts have issued reports on TRNS shares. Zacks Investment Research cut Transcat from a “hold” rating to a “strong sell” rating in a report on Tuesday, April 5th. StockNews.com started coverage on Transcat in a report on Thursday, March 31st. They issued a “hold” rating for the company. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and five have issued a buy rating to the company’s stock. According to MarketBeat.com, Transcat presently has an average rating of “Buy” and a consensus price target of $81.00.

About Transcat (Get Rating)

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates in two segments, Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.

Featured Stories

Want to see what other hedge funds are holding TRNS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Transcat, Inc. (NASDAQ:TRNSGet Rating).

Institutional Ownership by Quarter for Transcat (NASDAQ:TRNS)

Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.